Olympus enters co-development agreement to offer AI for colonoscopy: 4 insights

Olympus entered a co-development agreement with ai4gi to offer the Artificial Intelligence solution for real-time clinical decision support during screening and surveillance colonoscopy.

Here are four things to know.

1. Ai4gi is a commercial joint venture between Satis Operations and Imagia.

2. Ai4gi developed the clinical decision support tool using unaltered endoscopic colonoscopy videos from along with deep learning training models.

3. Olympus America will exclusively offer the Artificial Intelligence solution in the first co-development agreement of its kind in the U.S. market.

4. This marks the first time an AI proof-of-concept has been clinically demonstrated in real-time in a screening colonoscopy application.

More articles on gastroenterology:

GI Supply's Spot Ex Endoscopic Tattoo launches in Europe: 4 insights

GI leader to know: Dr. Paul Haynes of Indianapolis Gastroenterology and Hepatology

GI leader to know: Dr. Mark Scheidler of Northside Gastroenterology

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months